Combihale FF 250 Inhaler is a combination medication primarily used to prevent and treat symptoms of asthma and chronic obstructive pulmonary diseases (COPD) such as shortness of breath or wheezing (whistling sound while breathing). Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing. COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes).

Combihale FF 250 Inhaler is a combination of two drugs, namely: Formoterol (bronchodilator) and Fluticasone propionate (corticosteroid). Formoterol belongs to the class of bronchodilators that works by relaxing muscles and widening the airways of the lungs. Thus, it makes breathing easier. Fluticasone propionate belongs to the class of corticosteroids that works by acting inside cells of the nasal lining and stops the release of certain chemicals in the body that cause inflammatory reactions. Thereby, provides relief from sneezing, runny or blocked nose, and sinus discomfort.

Combihale FF 250 Inhaler is for inhalation only. Use Combihale FF 250 Inhaler as prescribed. Your doctor will recommend how often you take Combihale FF 250 Inhaler based on your medical condition. Some people may experience headache, sore throat, sneezing, stuffy nose, hoarse voice, cough, low fever, chest tightness, a fungal infection in the mouth, sinus pain, nausea, stomach upset, dizziness, nervousness, vomiting, or irregular heartbeat. Most of these side effects of Combihale FF 250 Inhaler do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Combihale FF 250 Inhaler or any other ingredients, please tell your doctor. If you are pregnant or breastfeeding, please inform your doctor before using Combihale FF 250 Inhaler. Combihale FF 250 Inhaler is not recommended for children below 12 years of age. Use of Combihale FF 250 Inhaler may worsen asthma symptoms in some patients. If you experience severe difficulty in breathing, please consult a doctor immediately so that alternative medicine may be prescribed. Regular monitoring of potassium levels is recommended while taking Combihale FF 250 Inhaler as it may cause low potassium levels in the blood. If you have high blood pressure, diabetes, chest or lungs infection, hyperthyroidism (overactive thyroid), hypokalaemia (low potassium levels in the blood), glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, heart, liver, or adrenal gland problems, inform your doctor before taking Combihale FF 250 Inhaler.

Combihale FF 250 Inhaler is a combination of two drugs, namely: Formoterol and Fluticasone propionate that is used to treat symptoms of asthma and chronic obstructive pulmonary diseases (COPD). Formoterol belongs to the class of bronchodilators that works by relaxing muscles and widening the airways of the lungs. Thus, it makes breathing easier. Fluticasone propionate belongs to the class of corticosteroids that works by acting inside cells of the nasal lining and stops the release of certain chemicals in the body that cause inflammatory reactions. Thereby, provides relief from sneezing, runny or blocked nose, and sinus discomfort.

If you are allergic to Combihale FF 250 Inhaler or any other ingredients, please tell your doctor. If you are pregnant or breastfeeding, please inform your doctor before using Combihale FF 250 Inhaler. Combihale FF 250 Inhaler is not recommended for children below 12 years of age. Use of Combihale FF 250 Inhaler may worsen asthma symptoms in some patients. If you experience severe difficulty in breathing, please consult a doctor immediately so that alternative medicine may be prescribed. Contact your doctor if you have blurred vision or any other vision disturbances while taking Combihale FF 250 Inhaler. Regular monitoring of potassium levels is recommended while taking Combihale FF 250 Inhaler as it may cause low potassium levels in the blood. If you have high blood pressure, diabetes, chest or lungs infection, hyperthyroidism (overactive thyroid), hypokalaemia (low potassium levels in the blood), glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, heart, liver or adrenal gland problems, inform your doctor before taking Combihale FF 250 Inhaler.

• Eat a healthy diet and exercise regularly to strengthen your breathing muscles and boost your immune system.
• Avoid foods such as cabbage, beans, garlic, onions, shrimp, pickled food, dried fruits, fried foods, carbonated drinks, wine, bottled lemon, and lime juice as it may worsen asthma symptoms.
• Do meditation, deep breathing, regular exercise, and try progressive muscle relaxation techniques to get relief from stress and reduce the risk of an asthma attack.
• Quit smoking as it may reduce the effectiveness of the Combihale FF 250 Inhaler and irritate the lungs worsening breathing problems.
• Learning breathing exercises will help you move more air in and out of your lungs.

Regular monitoring of blood sugar levels is recommended while taking Combihale FF 250 Inhaler especially if you have diabetes as it may increase blood sugar levels.

Asthma: It is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing. The symptoms of asthma include wheezing (whistling sound while breathing), shortness of breath, chest tightness, and cough, especially at night. The symptoms of mild persistent asthma may occur more than 2 times in a week and up to 4 nights in a month whereas, in the case of severe persistent asthma, the symptoms occur several times every day and most nights. The treatment for asthma includes medication, breathing exercises, and self-care.

Chronic obstructive pulmonary disease (COPD): It is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes). The major cause of COPD is smoking tobacco. Also, long-term exposure to fumes and chemicals may lead to COPD. The symptoms include chronic cough, shortness of breath, or wheezing (whistle sound while breathing).